Back to List View Graph View

Cognitive decline

Cognitive decline refers to a reduction in cognitive abilities such as memory, attention, executive function, processing speed, and learning.

Where the papers sit

10 papers from the last 6 months study cognitive decline directly · updated from PubMed 6 Nov 2026

  • Mild Cognitive Impairment

    Hippocampal network degeneration, especially in the right subiculum, is linked to amyloid-related memory loss and mild cognitive impairment. Population omics studies seek signatures of new-onset mild cognitive impairment and dementia. Modifiable and social contributors also recur, including uncorrected refractive error, presbyopia and spousal bereavement. The work is broadening cognitive-risk assessment beyond brain pathology alone.

    4 papers · 40%

  • Dementia Care and Aging

    Dementia care is moving toward support that preserves dignity, participation and aging in place. Swedish home-care services are being adapted to older adults’ preferences, while caregiver education is tested through a multicomponent School of Caring program. Aspiration pneumonia emerges as a marker of high healthcare utilisation in dementia. The shared focus is coordinated, person-centred care rather than disease-modifying treatment.

    3 papers · 30%

  • Metabolic Drivers of Dementia

    Metabolic dysfunction is being treated as a contributor to cognitive decline through insulin resistance, adiposity and neuroinflammation. Cohort work links insulin sensitivity with all-cause and cause-specific dementia risk, while dynamical models describe adiposity-related neurophysiological changes. AMPK activation by Aldometanib is being explored as a route to improve metabolic and cognitive dysfunction in aging. Whether metabolic correction prevents dementia remains open.

    3 papers · 30%

Papers

The 10 papers from the last 6 months that study cognitive decline directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Mild Cognitive Impairment (4)
  1. Evaluating the effect of spectacle correction for refractive errors and presbyopia on cognitive function in rural older adults in China: protocol for a randomised, parallel-group, superiority trial. BMJ open · 7 Oct 2026 PMID 42843862
  2. Loss of a spouse and risk of cognitive decline: insights from six prospective cohort studies. Epidemiology and psychiatric sciences · 30 Sept 2026 PMID 42813925
  3. Omics signature of new-onset mild cognitive impairment and dementia in a population-based study. Scientific reports · 16 Jun 2026 PMID 42303781
  4. Stage-specific hippocampal network degeneration links amyloid-cognition relationships: Right subiculum as structural substrate for memory maintenance and biomarker in amyloid-positive mild cognitive impairment. NeuroImage · 3 Jun 2026 PMID 42235661
Dementia Care and Aging (3)
  1. Aging in Place - A mixed methods study protocol of how care providers in Sweden organise and adapt granted home care services to the preferences and needs of people living with dementia. PloS one · 16 Jun 2026 PMID 42302009
  2. Multicomponent School of Caring Program to Support Caregivers of Patients With Dementia: A Quasi-Experimental Effectiveness Study in Primary Care. Annals of family medicine · 26 May 2026 PMID 42191378
  3. Aspiration Pneumonia as a Marker of a High Healthcare Utilisation Trajectory in Older Adults With Dementia: A Retrospective Cohort Study. Australasian journal on ageing · 22 May 2026 PMID 42168828
Metabolic Drivers of Dementia (3)
  1. Fractional-order dynamical modelling of neurophysiological reaction-diffusion model of adiposity-induced cognitive decline using physics-informed neural networks. Journal of biological physics · 15 Oct 2026 PMID 42878916
  2. AMPK activation by Aldometanib from Bigujing improves metabolic and cognitive dysfunction in aging mice. Metabolic brain disease · 12 Sept 2026 PMID 42730893
  3. Associations of Insulin Sensitivity with Risk of All-Cause and Cause-Specific Dementia: A Prospective Cohort Study. Molecular neurobiology · 18 Jul 2026 PMID 42470526

By study type

Clinical trials (1)
  1. Evaluating the effect of spectacle correction for refractive errors and presbyopia on cognitive function in rural older adults in China: protocol for a randomised, parallel-group, superiority trial. BMJ open · 7 Oct 2026 PMID 42843862
Observational studies and case reports (3)
  1. Loss of a spouse and risk of cognitive decline: insights from six prospective cohort studies. Epidemiology and psychiatric sciences · 30 Sept 2026 PMID 42813925
  2. Associations of Insulin Sensitivity with Risk of All-Cause and Cause-Specific Dementia: A Prospective Cohort Study. Molecular neurobiology · 18 Jul 2026 PMID 42470526
  3. Aspiration Pneumonia as a Marker of a High Healthcare Utilisation Trajectory in Older Adults With Dementia: A Retrospective Cohort Study. Australasian journal on ageing · 22 May 2026 PMID 42168828
Human data, design not indexed (4)
  1. Fractional-order dynamical modelling of neurophysiological reaction-diffusion model of adiposity-induced cognitive decline using physics-informed neural networks. Journal of biological physics · 15 Oct 2026 PMID 42878916
  2. Aging in Place - A mixed methods study protocol of how care providers in Sweden organise and adapt granted home care services to the preferences and needs of people living with dementia. PloS one · 16 Jun 2026 PMID 42302009
  3. Stage-specific hippocampal network degeneration links amyloid-cognition relationships: Right subiculum as structural substrate for memory maintenance and biomarker in amyloid-positive mild cognitive impairment. NeuroImage · 3 Jun 2026 PMID 42235661
  4. Multicomponent School of Caring Program to Support Caregivers of Patients With Dementia: A Quasi-Experimental Effectiveness Study in Primary Care. Annals of family medicine · 26 May 2026 PMID 42191378
Preclinical: animal, cell and lab studies (1)
  1. AMPK activation by Aldometanib from Bigujing improves metabolic and cognitive dysfunction in aging mice. Metabolic brain disease · 12 Sept 2026 PMID 42730893
Unclassified: not yet indexed with MeSH (1)
  1. Omics signature of new-onset mild cognitive impairment and dementia in a population-based study. Scientific reports · 16 Jun 2026 PMID 42303781